Dr. Robert C. Bocian, MD

Dr. Bocian practices at Surgery Center Palo Alto in Palo Alto, California.

Dr. Bocian's NPI, 1184633745, was assigned on August 5, 2006. Dr. Bocian graduated from University of Illinois College of Medicine - Chicago in 1987. Dr. Bocian holds California license G65716.

Dr. Bocian's primary practice is Surgery Center Palo Alto, at 795 El Camino Real, Palo Alto, CA 94301. The practice phone is (650) 324-1832.

Dr. Bocian's primary practice is Surgery Center Palo Alto in Palo Alto, California. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Bocian to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bocian practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Bocian's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Bocian is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Bocian's licenses on file in 2 states: California and New York.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, hives and immune deficiency disease among the conditions Dr. Bocian treats.

CMS data shows 3,700 Medicare services from Dr. Bocian across 9 procedure codes in 2024, for 209 Medicare patients. Medicare paid $71,770 for them. Every service was in an office.

CMS counts 209 Medicare patients who saw Dr. Bocian in 2024. The largest group is 65 to 74, with 98 patients. 71% of them have high cholesterol, and 51% have arthritis. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bocian's median patient age at 43, with 57% women.

In 2024, Dr. Bocian wrote 823 Medicare Part D claims for 171 patients. 59% of them were for generic drugs. CMS names the drug for 612 of them, across 24 drugs with 11 or more claims each, at $333,834 in total drug cost. In 2023, CMS named 505 claims across 16 drugs.

Dr. Bocian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bocian as offering telehealth.

Dmand AI links 5 papers to Dr. Bocian. The most frequent topics are Melphalan, Mice, Inbred BALB C and Plasmacytoma. Dr. Bocian has published most often in Cancer Immunol Immunother.

CMS Open Payments shows 133 general payments to Dr. Bocian from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. GlaxoSmithKline, LLC. paid the most, $647.

Dmand AI lists 4 awards for Dr. Bocian, most recently CMS Stage 1 EHR in 2013.

Dr. Bocian graduated from University of Illinois College of Medicine - Chicago in 1987. Dr. Bocian is a member of AAAAI.

Dr. Bocian is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.